---
title: "The Chinese team showcases new achievements in interventional treatment for heart disease in the United States"
description: "A Chinese research team presented a new medical device for treating aortic regurgitation and its latest clinical data at the Global Transcatheter Cardiovascular Therapeutics Annual Meeting in San Fran"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262742438.md"
published_at: "2025-10-26T03:08:03.000Z"
---

# The Chinese team showcases new achievements in interventional treatment for heart disease in the United States

> A Chinese research team presented a new medical device for treating aortic regurgitation and its latest clinical data at the Global Transcatheter Cardiovascular Therapeutics Annual Meeting in San Francisco, USA. The device, named "J-VALVE TF Transcatheter Aortic Valve System," achieves shorter surgery times and faster patient recovery through minimally invasive surgery, showcasing China's innovation and effectiveness in the medical device field

The Global Interventional Cardiovascular Therapy Conference 2025 opened on the 25th in San Francisco, California, USA. A Chinese research team presented the latest clinical data on medical devices for treating aortic regurgitation at the conference, showcasing the innovation, effectiveness, and safety of Chinese original devices. Academician of the Chinese Academy of Sciences and Professor Wang Jian'an from the Second Affiliated Hospital of Zhejiang University School of Medicine introduced the two-year clinical follow-up data of the "J-VALVE TF Transcatheter Aortic Valve System" for treating aortic regurgitation. This valve is accessed via a vascular approach, achieving a more minimally invasive treatment for aortic regurgitation through the synergistic innovation of device design and surgical techniques, resulting in shorter operation times and faster patient recovery

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 07:15 ETCardiac Surgeons at Allegheny General Hospital First in Region to Successfully Perform Transcatheter Tricuspid Valve Replacement Procedure | Cardiac experts at Allegheny General Hospital (AGH) have successfully performed the region's first transcatheter tricusp | [Link](https://longbridge.com/en/news/276440559.md) |
| TAVR-Fueled Growth and 2026 Guidance Might Change The Case For Investing In Edwards Lifesciences (EW) | Edwards Lifesciences reported Q4 2025 sales of $1.57 billion but saw a significant drop in net income. The company issue | [Link](https://longbridge.com/en/news/276405473.md) |
| Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth | Catheter Precision, Inc. has announced a strategic sale of its non-core atherectomy catheter technologies to enhance its | [Link](https://longbridge.com/en/news/276339751.md) |
| 11:03 ETNew Guidelines from NCCN Detail Fundamental Differences in Cancer in Children Compared to Adults | The National Comprehensive Cancer Network (NCCN) has released new Clinical Practice Guidelines for Pediatric Soft Tissue | [Link](https://longbridge.com/en/news/276145789.md) |
| Aurobindo Pharma says tax department demands recovery of refunds from co | Aurobindo Pharma says tax department demands recovery of refunds from co | [Link](https://longbridge.com/en/news/276319861.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.